Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Chika Sakai"'
Autor:
Noriyuki Naya, Chika Sakai, Daiki Okutsu, Ryo Kiguchi, Masakazu Fujiwara, Toshinaga Tsuji, Akira Iwanami
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 1, Pp 26-39 (2021)
Abstract Aim Previously, we reported on the efficacy and safety of guanfacine extended‐release (GXR) in Japanese adults with attention‐deficit/hyperactivity disorder (ADHD) from a phase 3, double‐blind, placebo‐controlled, randomized trial. I
Externí odkaz:
https://doaj.org/article/1afcbb99cc3145e18b16b6c7120876a2
Autor:
Yukiko Miyazaki, Daniel K. Inaoka, Tomoo Shiba, Hiroyuki Saimoto, Takaya Sakura, Eri Amalia, Yasutoshi Kido, Chika Sakai, Mari Nakamura, Anthony L. Moore, Shigeharu Harada, Kiyoshi Kita
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Human dihydroorotate dehydrogenase (HsDHODH) is a key enzyme of pyrimidine de novo biosynthesis pathway. It is located on the mitochondrial inner membrane and contributes to the respiratory chain by shuttling electrons to the ubiquinone pool. We have
Externí odkaz:
https://doaj.org/article/4343e700cc7f4f4caa097f95f6941062
Autor:
Ryo Kiguchi, Toshinaga Tsuji, Chika Sakai, Akira Iwanami, Masakazu Fujiwara, Noriyuki Naya, Daiki Okutsu
Publikováno v:
Neuropsychopharmacology Reports
Aim Previously, we reported on the efficacy and safety of guanfacine extended‐release (GXR) in Japanese adults with attention‐deficit/hyperactivity disorder (ADHD) from a phase 3, double‐blind, placebo‐controlled, randomized trial. In this ex
Autor:
Chika Sakai
Publikováno v:
Folia Pharmacologica Japonica. 155:413-425
Lisdexamfetamine dimesylate (hereinafter referred to as "lisdexamfetamine"; brand name, Vyvanse®), was developed for the treatment of attention-deficit/hyperactivity disorder (ADHD). This drug, which is classified as a central nervous system (CNS) s
Autor:
Chika Sakai, Noriyuki Naya, Sungeun Jung, Toshinaga Tsuji, Yirong Chen, Nobuhiro Nishigaki, Hirotaka Kosaka
Publikováno v:
Cureus
Background Symptoms experienced by adult patients with attention-deficit/hyperactivity disorder (ADHD) frequently result in functional impairment across academic/occupational functioning, daily life, and social functioning. A substantial proportion o
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(8)
Purpose As the cancer survivors increase, patients using long-term and high-dose opioids are also increasing. Therefore, the promotion of appropriate use is important. This study investigated the actual status of opioid prescriptions in Japan and ide
Autor:
Hisato Matsunaga, Hirokazu Mishima, Yuki Namba, Toru Nakai, Masakazu Fujiwara, Toshinaga Tsuji, Chika Sakai
Publikováno v:
Neuropsychiatric Disease and Treatment
Chika Sakai,1 Toshinaga Tsuji,1 Toru Nakai,1 Yuki Namba,1 Hirokazu Mishima,1 Masakazu Fujiwara,2 Hisato Matsunaga3 1Medical Affairs Department, Shionogi & Co. Ltd, Osaka, Japan; 2Data Science Office, Shionogi & Co. Ltd, Osaka, Japan; 3Department of N
Autor:
Akihiro, Tokunaga, Daisuke, Sugiyama, Yuka, Maeda, Allison Betof, Warner, Katherine S, Panageas, Sachiko, Ito, Yosuke, Togashi, Chika, Sakai, Jedd D, Wolchok, Hiroyoshi, Nishikawa
Publikováno v:
The Journal of Experimental Medicine
Corticosteroids inhibit antitumor immune responses of immune checkpoint blockade in a dose- and timing-dependent manner. Memory CD8+ T cells with low TCR affinity are selectively suppressed by corticosteroids, necessitating careful and thoughtful cor
Autor:
Takahiro Kinoshita, Chika Sakai, Yosuke Togashi, Masahito Kawazu, Masami Yamamoto, Eiichi Sato, Hiroyoshi Nishikawa, Toshihide Ueno, Akihito Kawazoe, Shogo Kumagai, Tetsuya Tsukamoto, Kohei Shitara, Hiroyuki Mano, Takeshi Kuwata, Sachiyo Nomura
Publikováno v:
Immunity. 53:187-203.e8
Only a small percentage of patients afflicted with gastric cancer (GC) respond to immune checkpoint blockade (ICB). To study the mechanisms underlying this resistance, we examined the immune landscape of GC. A subset of these tumors was characterized
Autor:
Chika, Sakai, Hiroyoshi, Nishikawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(2)
Tumor cells establish a unique circumstance called tumor microenvironment(TME)suitable for tumor development and progression. One ofthe most important advantages ofTME for tumor cells is immunosuppressive environment such as higher presence ofregulat